[220 U.S. 373, 374] This is a writ of certiorari to review a judgment of the circuit court of appeals for the sixth circuit which affirmed a judgment of the circuit court, dismissing, on demurrer, the bill of complaint for want of equity. 90 C. C. A. 579, 164 Fed. 803.
The complainant, Dr. Miles Medical Company, an Indiana corporation, if engaged in the manufacture and sale of proprietary medicines, prepared by means of secret methods and formulas, and identified by distinctive packages, labels, and trademarks. It has established an extensive trade throughout the United States and in certain foreign countries. It has been its practice to sell its medicines to jobbers and wholesale druggists, who in turn sell to retail druggists for sale to the consumer. In the case of each remedy, it has fixed not only the price of its own sales to jobbers and wholesale dealers, but also the wholesale and retail prices. The bill alleged that most of its sales were made through retail druggists, and that the demand for its remedies largely depended upon their [220 U.S. 373, 375] good will and commendation, and their ability to realize a fair profit; that certain retail establishments, particularly those known as department stores, had inaugurated a 'cutrate' or 'cut-price' system which had caused 'much confusion, trouble, and damage' to the complainant's business, and 'injuriously affected the reputation' and 'depleted the sales' of its remedies; that this injury resulted 'from the fact that the majority of retail druggists as a rule cannot, or believe that they cannot, realize sufficient profits' by the sale of the medicines 'at the cut-prices announced by the cut-rate and department stores,' and therefore are 'unwilling to, and do not keep' the medicines 'in stock,' or, 'if kept in stock, do not urge or favor sales thereof, but endeavor to foist off some similar remedy or substitute, and from the fact that in the public mind an article advertised or announced at 'cut' or 'reduced' price from the established price suffers loss of reputation and becomes of inferior value and demand.'
It was further alleged that for the purpose of protecting 'its trade sales and business' and of conserving 'its good will and reputation,' the complainant had established a method 'of governing, regulating, and controlling the sale and marketing' of its remedies, which is thus described in the bill:
As an aid to the maintenance of the prices thus fixed, the company devised a system for tracing and identifying, through serial numbers and cards, each wholesale and retail package of its products.
It was alleged that all wholesale and retail druggists, 'and all dealers in proprietary medicines,' had been given full opportunity, without discrimination, to sign contracts in the form stated, and that such contracts were in force between the complainant 'and over four hundred jobbers and wholesalers and twenty-five thousand retail dealers in proprietary medicines in the United States.'
The defendant is a Kentucky corporation conducting a wholesale drug business. The bill alleged that the defendant had formerly dealt with the complainant, and had full knowledge of all the facts relating to the trade in its medicines; that it had been requested, and refused, to enter into the wholesale contract required by the complainant; that in the city of Cincinnati, Ohio, where the defendant conducted a wholesale drug store, there were a large number of wholesale and retail druggists who had made contracts of the sort described, with the complainant, and kept its medicines on sale pursuant to the agreed terms and conditions. It was charged that the defendant, 'in combination and conspiracy with a number of wholesale and retail dealers in drugs and proprietary medicines, who have not entered into said wholesale and retail contracts' required by the complainant's system, and solely for the purpose of selling the remedies to dealers 'to be advertised, sold, and marketed at cut rates,' and 'to thus attract and secure custom and patronage for other merchandise, and not for the purpose of making or receiving a direct money profit' from the [220 U.S. 373, 382] sales of the remedies, had unlawfully and fraudulently procured them from the complainant's 'wholesale and retail agents' by means 'of false and fraudulent representations and statements, and by surreptitious and dishonest methods, and by persuading and inducing, directly and indirectly,' a violation of their contracts.
It is further charged that the defendant, having procured the remedies in this manner, had advertised and sold them at less than the jobbing and retail prices established by the complainant; and that, for the purpose of concealing the source of supply, the identifying serial numbers, which had been stamped upon the labels and cartons, had been obliterated by the defendant or by those acting in collusion with the defendant, and the labels and cartons had been mutilated, thus rendering the list of ailments and directions for use illegible, and that the remedies in this condition were sold both to the wholesale and retail dealers, and ultimately to buyers for use at cut rates.
The bill prayed for an injunction restraining the defendant from inducing or attempting to induce any party to any of the said 'wholesale or retail agency contracts' to 'violate or break the same, or to sell or deliver to the defendant, or to any person for it,' the complainant's remedies; from procuring or attempting to procure in any way any of these remedies from wholesale or retail dealers who had executed the contracts; from advertising, selling, or offering for sale the remedies obtained by any of the described means at less 'than the established retail price thereof,' or to dealers who had not entered into contract with the complainant; from in any way obliterating, mutilating, removing, or covering up the labels and cartons upon the bottles containing the remedies, and from making sales without such labels and cartons, and the letter press and numerals thereon, being intact. There was also a prayer for an accounting. [220 U.S. 373, 383] The defendant demurred to the bill generally for want of equity, and also specially to that portion of the bill which related to the mutilation and destruction of the identifying numbers and labels.
The circuit court sustained the demurrers and dismissed the bill, and its judgment was affirmed by the circuit court of appeals.
Messrs. Frank F. Reed and Edward S. Rogers for petitioner.
[220 U.S. 373, 389] Messrs. Alton B. Parker and William J. Shroder for respondent.
Mr. Justice Hughes, after making the above statement, delivered the opinion of the court:
The complainant, a manufacturer of proprietary medicines which are prepared in accordance with seeret formulas, presents by its bill a system, carefully devised, by which it seeks to maintain certain prices fixed by it for all the sales of its products, both at wholesale and retail. Its purpose is to establish minimum prices at which sales shall be made by its vendees and by all subsequent purchasers who traffic in its remedies. Its plan is thus to govern directly the entire trade in the medicines it manufactures, embracing interstate commerce as well as commerce within the state respectively. To accomplish this result it has adopted two forms of restrictive agreements limiting trade in the articles to those who become parties to one or the other. The one sort of contract, known as 'Consignment Contract-Wholesale,' has been made with over four hundred jobbers and wholesale dealers, and the other described as 'Retail Agency Contract,' with twenty-five thousand retail dealers in the United States.
The defendant is a wholesale drug concern which has refused to enter into the required contract, and is charged with procuring medicines for sale at 'cut prices' by inducing those who have made the contracts to violate the restrictions. The complainant invokes the established doctrine that an actionable wrong is committed by one who maliciously interferes with a contract between two parties, and induces one of them to break that contract, to the injury of the other, and that, in the absence of an ade- [220 U.S. 373, 395] quate remedy at law, equitable relief will be granted. Angle v. Chicago, St. P. M. & O. R. Co. 151 U.S. 1 , 38 L. ed. 55, 14 Sup. Ct. Rep. 240; Bitterman v. Louisville & N. R. Co. 207 U.S. 205 , 52 L. ed. 171, 28 Sup. Ct. Rep. 91, 12 A. & E. Ann. Cas. 693.
The principal question is as to the validity of the restrictive agreements.
Preliminarily there are opposing contentions as to the construction of the agreements, or, at least, of that made with jobbers and wholesale dealers. The complainant insists that the 'consignment contract' contemplates a true consignment for sale for account of the complainant, and that those who make sales under it are the complainant's agents, and not its vendees. The court below did not so construe the agreement, and considered it an effort 'to disguise the wholesale dealers in the mask of agency, upon the theory that in that character one link in the system for the suppression of the 'cut rate' business might be regarded as valid,' and that under this agreement 'the jobber must be regarded as the general owner, and engaged in selling for himself, and not as a mere agent of another.' 90 C. C. A. 581, 164 Fed. p. 805.
There are certain allegations in the bill which do not accord with the complainant's argument. Thus, it is alleged that it 'has been and is the uniform custom' of the complainant 'to sell said medicines, remedies, and cures to jobbers and wholesale druggists, who in turn sell and dispose of the same to retail druggists for sale and distribution to the ultimate purchaser or consumer.' And in setting forth the form of the agreement in question it is alleged that it was 'required to be executed by all jobbers and wholesale druggists to whom your orator sold its aforesaid remedies, medicines, and cures.' It is further stated that, as a means of maintaining 'said list of prices,' cards bearing serial identifying numbers are placed in each package of remedies 'sold to jobbers and wholesale druggists.' But it is also alleged in the bill that under the provisions [220 U.S. 373, 396] of the contract the title to the medicines remained in the complainant 'until actual sale in good faith to retail dealers, as therein provided.'
Turning to the agreement itself, we find that it purports to appoint the party with whom it is made one of the complainant's 'wholesale distributing agents,' and it is agreed that the complainant, as proprietor, shall consign to the agent 'for sale for the account of said proprietor' such goods as it may deem necessary, 'the title thereto to remain in the proprietor absolutely until sold under and in accordance with the provisions hereof, and all unsold goods to be immediately returned to said proprietor on demand and the cancelation of this agreement.' The goods are to be invoiced to the consignee at stated prices, which are the same as the minimum prices at which the consignee is allowed to sell. It is also agreed that the consignee shall 'faithfully and promptly account and pay to the proprietor the proceeds of all sales, after deducting as full compensation . . . a commission of 10 per cent of the invoice value, and a further commission of 5 per cent on the net amount of each consignment after deducting the said 10 per cent commission on all advances on account remitted within ten days from the date of any consignment,' such advances, however, not to affect the title to the goods, and to be repaid should the agreement be terminated and unsold goods, on which advances had been made, be returned. The consignee guarantees payment for all goods sold, and promises 'to render a full account and remit the net proceeds on the first day of each month of and for the sales of the month preceding.'
The consignee agrees 'to sell only to the designated retail agents of said proprietor, as specified in lists of such retail agents furnished by said proprietor, and alterable at the will of said proprietor.' A further provision permits sales 'only to the said retail or wholesale agents [220 U.S. 373, 397] of said proprietor, as per list furnished.' No time is fixed for the duration of the agreement.
It is urged that the additional commission of 5 per cent is to induce, through the guise of 'advances,' payment for the goods before sales are made, and that unsold goods are to be returned only on the complainant's demand and the cancelation of the agreement. But the consignee is not bound to make these 'advances,' and it is distinctly provided that he shall not acquire title by making them. It is also said that the consignee may sell at prices higher than those listed, but he is bound by the agreement to account for 'the proceeds of all slaes,' less the stipulated commissions. Nor is the provision as to the time for accounting and remittance of net proceeds to be regarded as inconsistent with agency, in the absence of a showing that, in the actual transactions and accounts, the consignee was treated as selling on his own behalf and paying as purchaser.
If, however, we consider the 'consignment contract' as one which in legal effect provides for consignments of goods to be sold by an agent for his principal's account, and that the tenor of the agreement, as set forth, must be taken to override the inconsistent general allegations to which we have referred, this alone would not be sufficient to support the bill.
The bill charges that the defendant has unlawfully and fraudulently procured the proprietary medicines from the complainant's 'wholesale and retail agents' in violation of their contracts. But it does not allege that the goods procured by the defendant from 'wholesale agents' were goods consigned to the latter for sale. The description 'wholesale agent' refers to those who have signed the 'consignment contract.' This contract, however, permits one 'wholesale agent' to sell to another 'wholesale agent.' For all that appears, the goods procured by the defendant may have been purchased by the defendant's [220 U.S. 373, 398] vendors from other wholesale agents. The bill avers that prior to the introduction of the described system, the defendant, a wholesale house, had dealt in the remedies, and had purchased them from the complainant and from 'wholesale druggists and jobbers.' There is nothing in the bill which is inconsistent with such an actual course of dealing, permitted by the agreement itself, with respect to the wholesale dealers who have signed it. But the goods which one wholesale agent purchased from another wholesale agent would not be held for sale as consigned goods belonging to the complainant, and to be accounted for as such; and their sale by the wholesale dealer, who had acquired title, would be made for his own account, and not for that of the complainant. The allegations of the bill and the plain purpose of the system of contracts do not permit the conclusion that it was intended that wholesale dealers purchasing goods in this way should be free to sell to anyone at any price. Evidently it was not contemplated that the restrictions of the system should be escaped in such a simple manner. But if the restrictions of the 'consignment contract' as to prices and vendees are to be deemed to apply to the sale of goods which one wholesale dealer has purchased from another, it is evident that the validity of the restrictions in this aspect must be supported on some other ground than that such sale is made by the wholesale dealer as the agent of the complainant. The case presented by the bill cannot properly be regarded as one for inducing breach of trust by an agent.
The other form of contract adopted by the complainant, while described as a 'retail agency contract,' is clearly an agreement looking to sale, and not to agency. The so-called 'retail agents' are not agents at all, either of the complainant or of its consignees, but are contemplated purchasers who buy to sell again; that is, retail dealers. It is agreed that they may purchase the medicines manu- [220 U.S. 373, 399] factured by the complainant at stated prices. There follows this stipulation:
It will be noticed that the 'retail agents' are not forbidden to sell either to wholesale or retail dealers if these are 'accredited agents' of the complainant, that is, if the dealers have signed either of the two contracts the complainant requires. But the restriction is intended to apply whether the retail dealers have bought the goods from those who held under consignment or from other dealers, wholesale or retail, who had purchased them. And in which way the 'retail agents' who supplied the medicines to the defendant had bought them is not shown.
The bill asserts complainant's 'right to maintain and preserve the aforesaid system and method of contracts and sales adopted and established by it.' It is, as we have seen, a system of interlocking restrictions by which the complainant seeks to control not merely the prices at which its agents may sell its products, but the prices for all sales by all dealers at wholesale or retail, whether purchasers or subpurchasers, and thus to fix the amount which the consumer shall pay, eliminating all competition. The essential features of such a system are thus described by Mr. Justice Lurton (then circuit judge), in the opinion of the circuit court of appeals in the case of John D. Park & Sons Co. v. Hartman, 12 L.R.A.(N.S.) on page 147, 82 C. C. A. 158, 153 Fed. 24: 'The contracting wholesalers or jobbers covenant that they will sell to no one who does not come with complainant's license to buy, and that they will not sell [220 U.S. 373, 400] below a minimum price dictated by complainant. Next, all competition between retailers is destroyed, for each such retailer can obtain his supply only by signing one of the uniform contracts prepared for retailers, whereby he covenants not to sell to anyone who proposes to sell again unless the buyer is authorized in writing by the complainant, and not to sell at less than a standard price named in the agreement. Thus all room for competition between retailers, who supply the public, is made impossible. If these contracts leave any room at any point of the line for the usual play of competition between the dealers in the product marketed by complainant, it is not discoverable. Thus a combination between the manufacturer, the wholesalers, and the retailers, to maintain prices and stifle competition, has been brought about.'
That these agreements restrain trade is obvious. That, having been made, as the bill alleges, with 'most of the jobbers and wholesale druggists and a majority of the retail druggists of the country,' and having for their purpose the control of the entire trade, they relate directly to interstate as well as intrastate trade, and operate to restrain trade or commerce among the several states, is also clear. Addyston Pipe & Steel Co. v. United States, 175 U.S. 211 , 44 L. ed. 136, 20 Sup. Ct. Rep. 96; E. Bement & Sons v. National Harrow Co. 186 U.S. 92 , 46 L. ed. 1069, 22 Sup. Ct. Rep. 747; W. W. Montague & Co. v. Lowry, 193 U.S. 38 , 48 L. ed. 608, 24 Sup. Ct. Rep. 307; Swift & Co. v. United States, 196 U.S. 375 , 49 L. ed. 518, 25 Sup. Ct. Rep. 276.
But it is insisted that the restrictions are not invalid either at common law or under the act of Congress of July 2, 1890, chap. 647, 26 Stat. at L. 209, U. S. Comp. Stat. 1901, p. 3200, upon the following grounds, which may be taken to embrace the fundamental contentions for the complainant: (1) That the restrictions are valid because they relate to proprietary medicines manufactured under a secret process; and (2) that, apart from this, a manufacturer is entitled to control the prices on all sales of his own products.
First. The first inquiry is whether there is any dis- [220 U.S. 373, 401] tinction, with respect to such restrictions as are here presented, between the case of an article manufactured by the owner of a secret process and that of one produced under ordinary conditions. The complainant urges an analogy to right secured by letters patent. E. Bement & Sons v. National Harrow Co. 186 U.S. 70 , 46 L. ed. 1058, 22 Sup. Ct. Rep. 747. In the case cited, there were licenses for the manufacture and sale of articles covered by letters patent, with stipulations as to the prices at which the licensee should sell. The court said, referring to the act of July 2, 1890 ( p. 92): 'But that statute clearly does not refer to that kind of a restraint of interstate commerce which may arise from reasonable and legal conditions imposed upon the assignee or licensee of a patent by the owner thereof, restricting the terms upon which the article may be used and the price to be demanded therefor. Such a construction of the act we have no doubt was never contemplated by its framers.'
But whatever rights the patentee may enjoy are derived from statutory grant under the authority conferred by the Constitution. This grant is based upon public considerations. The purpose of the patent law is to stimulate invention by protecting inventors for a fixed time in the advantages that may be derived from exclusive manufacture, use, and sale. As was said by Chief Justice Marshall in Grant v. Raymond, 6 Pet. pp. 241- 243, 8 L. ed. 384, 385: 'It is the reward stipulated for the advantages derived by the public for the exertions of the individual, and is intended as a stimulus to those exertions. . . . The public yields nothing which it has not agreed to yield; it receives all which it has contracted to receive. The full benefit of the discovery, after its enjoyment by the discoverer for fourteen years, is preserved; and for his exclusive enjoyment of it during that time the public faith is pledged. . . . The great object and intention of the act is to secure to the public the advantages to be derived from the discoveries of individuals, and the means it employs are the com- [220 U.S. 373, 402] pensation made to those individuals for the time and labor devoted to these discoveries, by the exclusive right to make, use, and sell the things discovered for a limited time.'
The complainant has no statutory grant. So far as appears, there are no letters patent relating to the remedies in question. The complainant has not seen fit to make the disclosure required by the statute, and thus to secure the privileges it confers. Its case lies outside the policies of the patent law, and the extent of the right which that law secures is not here involved or determined.
The complainant relies upon the ownership of its secret process and its rights are to be determined accordingly. Anyone may use it who fairly, by analysis and experiment, discovers it. But the complainant is entitled to be protected against invasion of its rights in the process by fraud or by breach of trust or contract. Tabor v. Hoffman, 118 N. Y. 36, 16 Am. St. Rep. 740, 23 N. E. 12; Chadwick v. Covell, 151 Mass. 190, 6 L.R.A. 839, 21 Am. St. Rep. 442, 23 N. E. 1068. The secret process may be the subject of confidential communication and of sale or license to use with restrictions as to territory and prices. Fowle v. Park, 131 U.S. 88 , 33 L. ed. 67, 9 Sup. Ct. Rep. 658. A similar principle obtains with respect to the confidential communication of quotations collected by a board of trade. Board of Trade v. Christie Grain & Stock Co. 198 U.S. 236 , 49 L. ed. 1031, 25 Sup. Ct. Rep. 637.
Here, however, the question concerns not the process of manufacture, but the manufactured product,-an article of commerce. The complainant has not communicated its process in trust, or under contract, or executed a license for the use of the process with restrictions as to the manufacturer and sale by the licensee to whom the communication is made. The complainant has retained its secret, which apparently it believes to be undiscoverable. Whether its remedies are sold or unsold, whether the restrictions as to future sales are valid or invalid, the complainant's secret remains intact. That the complainant may rightfully ob- [220 U.S. 373, 403] ject to attempts to discover it by fraudulent means, or to a breach of trust or contract relating to the process, does not require the conclusion that it is entitled to establish restrictions with respect to future sales by those who purchase its manufactured product. It is said that the remedies 'embody' the secret. It would be more correct to say that they are manufactured according to the secret process, and do not constitute a communication of it. It is also urged that, as the process is secret, no one else can manufacture the article. But this argument rests on monopoly of production, and not on the secrecy of the process or the particular fact that may confer that monopoly. It implies that if, for any reason, monopoly of production exists, it carries with it the right to control the entire trade of the produced article, and to prevent any competition that otherwise might arise between wholesale and retail dealers. The principle would not be limited to secret processes, but would extend to goods manufactured by anyone who secured control of the source of supply of a necessary raw material or ingredient. But, because there is monopoly of production, it certainly cannot be said that there is no public interest in maintaining freedom of trade with respect to future sales after the article has been placed on the market and the producer has parted with his title. Moreover, every manufacturer, before sale, controls the articles he makes. With respect to these, he has the rights of ownership, and his dominion does not depend upon whether the process of manufacture is known or unknown, or upon any special advantage he may possess by reason of location, materials, or efficiency. The fact that the market may not be supplied with the particular article unless he produces it is a practical consequence which does not enlarge his right of property in what he does produce.
If a manufacturer, in the absence of statutory privilege, has the control over the sales of the manufactured article [220 U.S. 373, 404] for which the complainant here contends, it is not because the process of manufacture is kept secret. In this respect, the maker of so-called proprietary medicines, unpatented, stands on no different footing from that of other manufacturers. The fact that the article is represented to be curative in its properties does not justify a restriction of trade which would be unlawful as to compositions designed for other purposes.
Second. We come, then, to the second question,-whether the complainant, irrespective of the secrecy of its process, is entitled to maintain the restrictions by virtue of the fact that they relate to products of its own manufacture.
The basis of the argument appears to be that, as the manufacturer may make and sell, or not, as he chooses, he may affix conditions as to the use of the article or as to the prices at which purchasers may dispose of it. The propriety of the restraint is sought to be derived from the liberty of the producer.
But because a manufacturer is not bound to make or sell, it does not follow in case of sales actually made he may impose upon purchasers every sort of restriction. Thus, a general restraint upon alienation is ordinarily invalid. 'The right of alienation is one of the essential incidents of a right of general property in movables, and restraints upon alienation have been generally regarded as obnoxious to public policy, which is best subserved by great freedom of traffic in such things as pass from hand to hand. General restraint in the alienation of articles, things, chattels, except when a very special kind of property is involved, such as a slave or an heirloom, have been generally held void. 'If a man,' says Lord Coke, in 2 Coke on Littleton, 360, 'be possessed . . . of a horse or of any other chattel, real or personal, and give or sell his whole interest or property therein, upon condition that the donee or vendee shall not alien the same, the same is void, because the whole interest and property is out of him, so as he hath [220 U.S. 373, 405] no possibility of a reverter; and it is against trade and traffic and bargaining and contracting between man and man." John D. Park & Sons Co. v. Hartman, 12 L.R.A.(N.S.) 146, 82 C. C. A. 158, 153 Fed. 24. See also Gray, Restraints on Alienation of Property, 27, 28.
Nor can the manufacturer by rule and notice, in the absence of contract or statutory right, even though the restriction be known to purchasers, fix prices for future sales. It has been held by this court that no such privilege exists under the copyright statutes, although the owner of the copyright has the sole right to vend copies of the copyrighted production. Bobbs-Merrill Co. v. Straus, 210 U.S. 339 , 52 L. ed. 1086, 28 Sup. Ct. Rep. 722. There the court said (p. 351): 'The owner of the copyright in this case did sell copies of the book in quantities and at a price satisfactory to it. It has exercised the right to vend. What the complainant contends for embraces not only the right to sell the copies, but to qualify the title of a future purchaser by the reservation of the right to have the remedies of the statute against an infringer because of the printed notice of its purpose so to do unless the purchaser sells at a price fixed in the notice. To add to the right of exclusive sale the authority to control all future retail sales, by a notice that such sales must be made at a fixed sum, would give a right not included in the terms of the statute, and, in our view, extend its operation, by construction, beyond its meaning, when interpreted with a view to ascertaining the legislative intent in its enactment.' It will hardly be contended, with respect to such a matter, that the manufacturer of an article of commerce not protected by any statutory grant is in any better case. See Taddy & Co. v. Sterious & Co. [220 U.S. 373, 1904] 1 Ch. 354; McGruther v. Pitcher [220 U.S. 373, 1904] 2 Ch. 306; Garst v. Hall & L. Co. 179 Mass. 588, 55 L.R.A. 631, 61 N. E. 219. Whatever right the manufacturer may have to project his control beyond his own sales must depend not upon an inherent power incident to production and original ownership, but upon agreement. [220 U.S. 373, 406] With respect to contracts in restraint of trade, the earlier doctrine of the common law has been substantially modified in adaptation to modern conditions. But the public interest is still the first consideration. To sustain the restraint, it must be found to be reasonable both with respect to the public and to the parties, and that it is limited to what is fairly necessary, in the circumstances of the particular case, for the protection of the covenantee. Otherwise restraints of trade are void as against public policy. As was said by this court in Gibbs v. Consolidated Gas. Co. 130 U.S. 409 , 32 L. ed. 984, 9 Sup. Ct. Rep. 553: 'The decision in Mitchel v. Reynolds, 1 P. Wms. 181, s. c. 1 Smith, Lead. Cas. 7th Eng. ed. 407; 8th Am. ed. 756, is the foundation of the rule in relation to the invalidity of contracts in restraint of trade; but as it was made under a condition of things and a state of society different from those which now prevail, the rule laid down is not regarded as inflexible, and has been considerably modified. Public welfare is first considered, and if it be not involved, and the restraint upon one party is not greater than protection to the other party requires, the contract may be sustained. The question is whether, under the particular circumstances of the case and the nature of the particular contract involved in it, the contract is, or is not, unreasonable. Rousillon v. Rousillon, L. R. 14 Ch. Div. 351; Leather Cloth Co. v. Lorsont, L. R. 9 Eq. 345.'
The present case is not analogous to that of a sale of good will, or of an interest in a business, or of the grant of a right to use a process of manufacture. The complainant has not parted with any interest in its business or instrumentalities of production. It has conferred no right by virtue of which purchasers of its products may compete with it. It retains complete control over the business in which it is engaged, manufacturing what it pleases and fixing such prices for its own sales as it may desire. Nor are we dealing with a single transaction, conceivably unrelated to the public interest. The agreements are designed to maintain prices after the complainant has parted with the title to the articles, and to prevent competition among those who trade in them.
The bill asserts the importance of a standard retail price, and alleges generally that confusion and damage have resulted from sales at less than the prices fixed. But the advantage of established retail prices primarily concerns the dealers. The enlarged profits which would result from adherence to the established rates would go to them, and not to the complainant. It is through the inability of the favored dealers to realize these profits, on account of the described competition, that the complainant works out its alleged injury. If there be an advantage to the manufacturer in the maintenance of fixed retail prices, the question remains whether it is one which he is entitled to secure by agreements restricting the freedom of trade on the part of dealers who own what they [220 U.S. 373, 408] sell. As to this, the complainant can fare no better with its plan of identical contracts than could the dealers themselves if they formed a combination and endeavored to establish the same restrictions, and thus to achieve the same result, by agreement with each other. If the immediate advantage they would thus obtain would not be sufficient to sustain such a direct agreement, the asserted ulterior benefit to the complainant cannot be regarded as sufficient to support its system.
But agreements or combinations between dealers, having for their sole purpose the destruction of competition and the fixing of prices, are injurious to the public interest and void. They are not saved by the advantages which the participants expect to derive from the enhanced price to the consumer. People v. Sheldon, 139 N. Y. 251, 23 L.R.A. 221, 36 Am. St. Rep. 690, 34 N. E. 785; Judd v. Harrington, 139 N. Y. 105, 34 N. E. 790; People v. Milk Exch. 145 N. Y. 267, 27 L.R.A. 437, 45 Am. St. Rep. 609, 39 N. E. 1062; United States v. Addyston Pipe & Steel Co. 46 L.R.A. 122, 29 C. C. A. 141, 54 U. S. App. 723, 85 Fed. 271, on appeal 175 U.S. 211 , 44 L. ed. 136, 20 Sup. Ct. Rep. 96; W. W. Montague & Co. v. Lowry, 193 U.S. 38 , 48 L. ed. 608, 24 Sup. Ct. Rep. 307; Chapin v. Brown Bros. 83 Iowa, 156, 12 L.R.A. 428, 32 Am. St. Rep. 297, 48 N. W. 1074; Craft v. McConoughy, 79 Ill. 346, 22 Am. Rep. 171; W. H. Hill Co. v. Gray & Worcester, -- Mich. --, 30 L.R.A.(N.S.) 327, 127 N. W. 803.
The complainant's plan falls within the principle which condemns contracts of this class. It, in effect, creates a combination for the prohibited purposes. No distinction can properly be made by reason of the particular character of the commodity in question. It is not entitled to special privilege or immunity. It is an article of commerce, and the rules concerning the freedom of trade must be held to apply to it. Nor does the fact that the margin of freedom is reduced by the control of production make the protection of what remains, in such a case, a negligible matter. And where commodities have passed into the channels of trade and are owned by dealers, the validity of agreements to prevent competition and to maintain prices is not to be determined by the circumstance whether they were produced by several manufacturers or by one, [220 U.S. 373, 409] or whether they were previously owned by one or by many. The complainant having sold its product at prices satisfactory to itself, the public is entitled to whatever advantage may be derived from competition in the subsequent traffic.
The questions involved were carefully considered and the decisions reviewed by Judge Lurton in delivering the opinion of the circuit court of appeals in John D. Park & Sons Co. v. Hartman, supra, and, in following that case, it was concluded below that the restrictions sought to be enforced by the bill were invalid both at common law and under the act of Congress of July 2, 1890. We think that the court was right.
The allegations of the bill as to the labels and cartons used by the complainant are evidently incidental to the main charge as to the procurement of violation of the restrictions as to prices and vendees contained in the agreement; and failing as to this, no case is made for relief with respect to the trademarks, which are not shown to have been infringed.
Mr. Justice Lurton took no part in the consideration and decision of this case.
Mr. Justice Holmes, dissenting:
This is a bill to restrain the defendant from inducing, by corruption and fraud, agents of the plaintiff and purchasers from it to break their contracts not to sell its goods below a certain price. There are two contracts concerned. The first is that of the jobber or wholesale agent to whom the plaintiff consigns its goods; and I will say a few words about that, although it is not this branch of the case that induces me to speak. That they are agents, and not buyers, I understand to be conceded, and I do not see how it [220 U.S. 373, 410] can be denied. We have nothing before us but the form and the alleged effect of the written instrument, and they both are express that the title to the goods is to remain in the plaintiff until actual sale as permitted by the contract. So far as this contract limits the authority of the agents as agents, I do not understand its validity to be disputed. But it is construed also to permit the purchase of medicine by consignees from other consignees, and to make the specification of prices applicable to goods so purchased as well as to goods consigned. Hence, when the bill alleges that the defendant has obtained medicine from these agents by inducing them to break their contracts, the allegation does not require proof of breach of trust by an agent, but would be satisfied by proving a breach of promise in respect of goods that the consignee had bought and owned. This reasoning would have been conclusive in the days of Saunders if the construction of the contract is right, as I suppose that it is. But the contract as to goods purchased is at least in the background and obscure; it is not the main undertaking that the instrument is intended to express. I should have thought that the bill ought to be read as charging the defendant with inducing a breach of the ordinary duty of consignees as such (Swift & Co. v. United States, 196 U.S. 375, 395 , 49 S. L. ed. 518, 523, 25 Sup. Ct. Rep. 276), and therefore as entitling the plaintiff to relief ( Angle v. Chicago, St. P. M. & O. R. Co. 151 U.S. 1 , 38 L. ed. 55, 14 Sup. Ct. Rep. 240).
The second contract is that of the retail agents, so called, being really the first purchasers, fixing the price below which they will not sell to the public. There is no attempt to attach a contract or condition to the goods, as in Bodds-Merrill Co. v. Straus, 210 U.S. 339 , 52 L. ed. 1086, 28 Sup. Ct. Rep. 722, or in any way to restrict dealings with them after they leave the hands of the retail men. The sale to the retailers is made by the plaintiff, and the only question is whether the law forbids a purchaser to contract with his vendor that he will not sell [220 U.S. 373, 411] below a certain price. This is the important question in this case. I suppose that in the case of a single object, such as a painting or a statute, the right of the artist to make such a stipulation hardly would be denied. In other words, I suppose that the reason why the contract is held bad is that it is part of a scheme embracing other similar contracts, each of which applies to a number of similar things, with the object of fixing a general market price. This reason seems to me inadequate in the case before the court. In the first place, by a slight change in the form of the contract the plaintiff can accomplish the result in a way that would be beyond successful attack. if it should make the retail dealers also agents in law as well as in name, and retain the title until the goods left their hands, 1 cannot conceive that even the present enthusiasm for regulating the prices to be charged by other people would deny that the owner was acting within his rights. It seems to me that this consideration by itself ought to give us pause.
But I go farther. There is no statute covering the case; there is no body of precedent that, by ineluctable logic, requires the conclusion to which the court has come. The conclusion is reached by extending a certain conception of public policy to a new sphere. On such matters we are in perilous country. I think that at least it is safe to say that the most enlightened judicial policy is to let people manage their own business in their own way, unless the ground for interference is very clear. What, then, is the ground upon which we interfere in the present case? Of course, it is not the interest of the producer. No one, I judge, cares for that. It hardly can be the interest of subordinate vendors, as there seems to be no particular reason for preferring them to the originator and first vendor of the product. Perhaps it may be assumed to be the interest of the consumers and the public. On that point I confess that I am in a minority as to larger issues than [220 U.S. 373, 412] are concerned here. I think that we greatly exaggerate the value and importance to the public of competition in the production or distribution of an article (here it is only distribution) as fixing a fair price. What really fixes that is the competition of conflicting desires. We, none of us, can have as much as we want of all the things that we want. Therefore, we have to choose. As soon as the price of something that we want goes above the point at which we are willing to give up other things to have that, we cease to buy it and buy something else. Of course, I am speaking of things that we can get along without. There may be necessaries that sooner or later must be dealt with like short rations in a shipwreck, but they are not Dr. Miles's medicines. With regard to things like the latter, it seems to me that the point of most profitable returns marks the equilibrium of social desires, and determines the fair price in the only sense in which I can find meaning in those words. The Dr. Miles Medical Company knows better than we do what will enable it to do the best business. We must assume its retail price to be reasonable, for it is so alleged and the case is here on demurrer; so I see nothing to warrant my assuming that the public will not be served best by the company being allowed to carry out its plan. I cannot believe that in the long run the public will profit by this court permitting knaves to cut reasonable prices for some ulterior purpose of their own, and thus to impair, if not to destroy, the production and sale of articles which it is assumed to be desirable that the public should be able to get.
The conduct of the defendant falls within a general prohibition of the law. It is fraudulent, and has no merits of its own to recommend it to the favor of the court. An injunction against a defendant's dealing in nontransferable round-trip reduced-rate tickets has been granted to a railroad company upon the general principles of the law protecting contracts, and the demoralization of rates has [220 U.S. 373, 413] been referred as a special circumstance in addition to the general grounds. Bitterman v. Louisville & N. R. Co. 207 U.S. 205 , 222-224, 52 L. ed. 171, 182, 183, 28 Sup. Ct. Rep. 91, 12 A. & E. Ann. Cas. 693. The general and special considerations equally apply here, and we ought not to disregard them, unless the evil effect of the contract is very plain. The analogy relied upon to establish that evil effect is that of combinations in restraint of trade. I believe that we have some superstitions on that head, as I have said; but those combinations are entered into with intent to exclude others from a business naturally open to them, and we unhappily have become familiar with the methods by which they are carried out. I venture to say that there is no likeness between them and this case (Jayne v. Loder, 7 L.R.A.(N.S.) 984, 78 C. C. A. 653, 149 Fed. 21, 27, 9 A. & E. Ann. Cas. 294), and I think that my view prevails in England (Elliman, Sons & Co. v. Carrington & Son [220 U.S. 373, 1901] 2 Ch. 275). See Garst v. Harris, 177 Mass. 72, 58 N. E. 174. Garst v. Charles, 187 Mass. 144, 72 N. E. 839. I think also that the importance of the question and the popularity of what I deem mistaken notions makes it my duty to express my view in this dissent.